Delphine Diagnostics

05/01/2023

Panel on Use of Academic and Federal Core Research/Lab Facilities in New Jersey
Princeton, NJ. March 15, 2023: The panel discussion on “Use of Academic and Federal Core Research/Lab Facilities in New Jersey” was a highly informative and beneficial event we recently attended. The panelists were experts in their respective fields. They provided valuable insights into how to access New Jersey’s academic, federal, and nonprofit core labs to accelerate research and development through the Commission on Science Innovation and Technology’s Catalyst and Clean Tech R&D Voucher Grant Program.

The panel was comprised of distinguished individuals such as Vince Smeraglia from Rutgers University, Alex Norman from Princeton University, Irene Wei from CSR Pharma Group, Frances Keel from CSIT, and Nyron Khan from Six Therapeutics. They shared their expertise and answered several questions from the audience, which included entrepreneurs, startup founders, and early-stage firms.

Judith Sheft initiated the panel discussion from CSIT, and Mahako Etta from the same organization moderated the event. The panel was hosted at the Biolabs facility in Princeton, which provided an ideal setting for the discussion.

Overall, the panel discussion provided several key takeaways that will be invaluable for founders of NJ-based startups and early-stage firms. The event was well-organized and highly informative, and we would like to thank the organizers and hosts for their efforts in putting together such a value-added event.

05/01/2023

Delphine Diagnostics is at the Roundtable Discussion in Camden
Camden, NJ. April 2023:
New Jersey’s Commission on Science, Innovation, and Technology (CSIT) recently organized a valuable event at Rutgers and Rowan University’s Translational Research Facility in Camden, NJ during the last quarter. Delphine Diagnostics was invited to participate in this state-level round table discussion to address pressing issues and challenges facing the life sciences ecosystem.

During the discussion, two key topics were explored:
Q1: Support from the State – What specific type of support would be most impactful for companies like Delphine Diagnostics to grow their business in New Jersey?
Q2: Talent Acquisition – What specific positions do companies like Delphine Diagnostics need to fill for current vacancies and projected future hiring needs to support their growth?

After the discussion, a follow-up communication was shared earlier this month, which included actionable items to address the concerns raised during the round table. Overall, the event proved to be a valuable opportunity for Delphine Diagnostics and other life sciences companies to engage with CSIT and discuss critical issues facing their industry in New Jersey.

Delphine Diagnostics is very grateful to the Executive Leadership and Organizing Committee Members of NJ CSIT, NJ EDA, and NJ DOL for their efforts in organizing this valuable event. It’s clear that this is a positive trend and the engaging and value-add conversation provided an excellent opportunity for industry leaders to come together and discuss critical issues facing the life sciences ecosystem in New Jersey.

The collaborative efforts of these organizations are appreciated and demonstrate a commitment to supporting companies like Delphine Diagnostics as they work to grow and develop within the state. We are grateful for the opportunity to participate in this round table discussion and look forward to continued engagement with NJ CSIT, NJ EDA, and NJ DOL in the future.

04/20/2023

Delphine is now in the process of developing a novel technology that will improve the speed and accuracy of sepsis diagnostic testing.

Delphine has partnered with Rutgers University to collaboratively support the development of students in various disciplines during the past two years. As a part of this continuing effort, during Spring 2023, Delphine is currently working with a talented group of graduate students from the Rutgers Business School(RBS) in the Health Care Analytics Program.

The RBS students bring great practical experience to the Life Sciences field with a mix of training and work experience in medicine, chemistry, and business disciplines.

The students engaged in conducting primary market research from key healthcare opinion leaders and stakeholders with deep sepsis knowledge from the perspective of physicians, hospital administrators, lab technicians, and insurance payers.

The team will also conduct secondary research to develop an assessment of the sepsis diagnostic market and the competitive landscape. The work done with the Rutgers Business School is highly valuable and will enable Delphine Diagnostics to better navigate its roadmap to the commercialization of a next-generation sepsis diagnostic test that can improve care and positively improve healthcare costs.

RBS Students led by George Hseeh, Stephen Barr, Iram Contractor, Lakshmi Narayanan Ramalingam visited Delphine’s Lab at Kean University on April 7th.
Delphine’s Team was led by Andy Bala(Founder), Mary Stack, Sreyashi Samaddar, Isis Gonzalez, and Poonam Talreja.

09/27/2022

09/21/2022

Another great event from BioNJ: BioNJ Manufacturing Briefing 2022. The event was in-person, and we enjoyed the valuable presentations, networking, and the tour of McKinsey's Digital Capability Center. We made great connections to partner up and manufacture our upcoming product, Sepsis Diagnostic Kit, here in New Jersey. BioNJ

07/08/2022

DELPHINE DIAGNOSTICS INC BECAME AN INAUGURAL MEMBER OF THE SEPSIS INNOVATION COLLABORATIVE (SIC)
https://delphinedx.com/recent-news/?v=914fddbcac3b

DELPHINE DIAGNOSTICS INC BECAME AN INAUGURAL MEMBER OF THE SEPSIS INNOVATION COLLABORATIVE (SIC) Great news from the Delphine team! Delphine Diagnostics accepted an invitation to join as an inaugural member of the Sepsis Innovation Collaborative (SIC) led by Sepsis Alliance. Delphine’s CEO, Andy B...

05/18/2022

BIONJ’S TWELFTH ANNUAL BIOPARTNERING CONFERENCE – 2022
BioNJ organized a BioPartnering networking event on May 9, 2022, in Liberty Park, New Jersey. Andy Bala of Delphine Diagnostics was invited as a guest of BioNJ; it was a great turnout for all.

05/08/2022

THE STATE OF THE STATE OF MANUFACTURING – 2022
https://delphinedx.com/recent-news/?v=914fddbcac3b

02/22/2022

https://conta.cc/3h4xevZ

Delphine Diagnostics PrecisQT™ RT PCR Test Kit Dear Asli, We hope you are doing well and staying healthy. At Delphine Diagnostics, we are deeply committed to improving the diagnosis of infectious dise

12/31/2021